Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Wellcome Centre for Human Genetics researcher Dr Ross Chapman has been selected as one of the European Molecular Biology Organisation's Young Investigators for 2018.

Ross Chapman

The EMBO Young Investigator Programme identifies recent group leaders with a proven record of scientific excellence and offers them access to a range of benefits during their four-year tenure. These include an award of 15,000 euros, with the potential for additional funding, mentorship by a senior scientist from the community of EMBO Members, access to training in leadership skills and responsible research practices, as well as networking opportunities.

Additional benefits provided by the Programme include the use of core facilities at the European Molecular Biology Laboratory in Heidelberg, Germany, and travel grants for the Young Investigators and their research groups to attend conferences.

“The accepted candidates have all shown outstanding promise in their early careers and impressed our selection committee with both the quality of their current work and their proposals for future research:” said EMBO Director, Maria Leptin. “We look forward to supporting them in establishing their own research groups.”

Dr Ross Chapman commented: “I’m thrilled for having been selected as an EMBO Young Investigator. It’s going to be great to interact with a community of young scientists involved in exciting and cutting-edge research. I’m also very grateful for the benefits its going to bring to my group. The EMBO young investigator programme comes with lots of opportunities for my team members to interact with scientists across Europe, and also allows them to apply for travel grants and receive training. Most importantly, this support from EMBO is aimed towards increasing the visibility of my group's research, and this is also going to profit the whole team.”

The 2018 group of Young Investigators comprises scientists based in 11 countries, including two European Molecular Biology Conference (EMBC) Associate Member States: India and Singapore.

The next application deadline is 1 April 2019. More information is available at http://www.embo.org/funding-awards/young-investigators